Why the study?
Does off-pump CABG improve safety and reduce morbidity compared to conventional CABG with cardiopulmonary bypass in patients with coronary artery disease?
Does off-pump CABG improve safety and reduce morbidity compared to conventional CABG with cardiopulmonary bypass in patients with coronary artery disease?
Existing evidence from randomized trials does not conclusively show an advantage of off-pump CABG over conventional CABG, indicating the need for larger prospective trials.
Answers are grounded in this paper and cite their sources.
Inconclusive RCT evidence precludes preferring off-pump CABG; leaves open whether larger trials will resolve equipoise in revascularization.
Coronary artery bypass grafting (CABG) performed with cardiopulmonary bypass has become a well-established treatment modality for patients with coronary artery disease. However, there is increasing evidence that cardiopulmonary bypass may be responsible for some of the morbidity associated with CABG surgery. Thus, it has been proposed that CABG surgery would be safer if cardiopulmonary bypass could be avoided. The development of cardiac stabilization devices has allowed for the creation of safe and reproducible coronary anastomoses on the beating heart. Several large, non-randomized, retrospective case series have demonstrated that CABG surgery can be performed safely without cardiopulmonary bypass (off-pump) and have in fact suggested benefits when compared with conventional CABG. However, the randomized controlled studies published to date have, as a whole, been unable to conclusively demonstrate the advantages of off-pump surgery. Taken together, the evidence to date suggests that a large-scale, prospective, randomized trial may be required to resolve the dilemma.
No takes yet. Share an insight, caveat, or question.
Jean‐François Légaré (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: